Article Text

Download PDFPDF
Microsatellite instability—a useful diagnostic tool to select patients at high risk for hereditary non-polyposis colorectal cancer: a study in different groups of patients with colorectal cancer
  1. C Lambertia,
  2. R Kruseb,
  3. C Ruelfsb,
  4. R Casparia,
  5. Y Wangb,
  6. M Jungckb,
  7. M Mathiakc,
  8. H R H Malayerib,
  9. W Friedlb,
  10. T Sauerbrucha,
  11. P Proppingb
  1. aDepartment of Internal Medicine, University of Bonn, Bonn, Germany, bInstitute of Human Genetics, University of Bonn, Bonn, Germany, cDepartment of Pathology, University of Bonn, Bonn, Germany
  1. Dr C Lamberti, Department of Internal Medicine, University of Bonn, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany.

Abstract

BACKGROUND Clinical diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) is based on a typical family history. As molecular genetic testing is predominantly restricted to these families, gene carriers not meeting the clinical criteria may be missed.

AIMS To examine the value of microsatellite instability (MSI) as a tool to increase the likelihood for uncovering a mismatch repair germline mutation in patients with colorectal cancer and to identify a genotype-phenotype relation in families with verified mutations.

METHODS Systematic search for germline mutations (hMSH2 and hMLH1 genes) was performed in 96 patients: 57 fulfilled the Amsterdam criteria (group 1) and 12 the looser HNPCC criteria (group 2). Seventeen patients showed familial clustering of cancers (group 3) and 10 patients under 50 years had sporadic cancer (group 4), the latter of whom all exhibited MSI+ tumours.

RESULTS A similar proportion of germline mutations was found in patients who fulfilled the clinical criteria of HNPCC and had MSI+ tumours (groups 1 and 2; 15/39) compared with patients who did not meet these clinical criteria but who had MSI+ tumours (groups 3 and 4; 8/27 patients). Affected relatives of patients with hMLH1 mutations showed a significantly higher frequency of colorectal cancer but a lower frequency of endometrium cancer than those with hMSH2 mutations.

CONCLUSIONS MSI in tumour tissue is a useful criterion for selecting patients who should be tested for germline mutations in the mismatch repair genes hMSH2 and hMLH1 irrespective of their family history. Among carriers of hMSH2 mutations the tumour spectrum was broader than among carriers of hMLH1 mutations.

  • hereditary non-polyposis colorectal cancer
  • sporadic colorectal cancer
  • microsatellite instability
  • germline mutations
  • genotype phenotype relation
  • Abbreviations

    HNPCC
    hereditary non-polyposis colorectal cancer
    MSI
    microsatellite instability
    SSCA
    single strand conformation analysis
    HA
    heteroduplex analysis
    PCR
    polymerase chain reaction
  • Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

  • Abbreviations

    HNPCC
    hereditary non-polyposis colorectal cancer
    MSI
    microsatellite instability
    SSCA
    single strand conformation analysis
    HA
    heteroduplex analysis
    PCR
    polymerase chain reaction
  • View Full Text